Introduction
Understanding the pathogenic mechanism of a mental disorder in terms of molecular changes in specific neural circuitries pre sents one of the major challenges in neurobiological studies of psychiatric diseases. Phospholipase Cβ1 (PLCβ1) is a phosphoinositidespecific phosphodiesterase that is readi ly ac tivated by Gq proteincoupled neurotransmitter receptors, such as muscarinic acetylcholine receptors, group 1 metabotropic glutamate receptors and serotonergic re ceptors. [1] [2] [3] [4] PLCβ1 hy drolyzes phosphatidylinositol 4,5bisphosphate to produce a pair of second messengers: diacylglycerol (DAG) and inositol 1,4,5trisphosphate (IP 3 ). 5 In general, DAG stimulates the phos phorylating enzyme, protein kinase C, whereas IP 3 mobilizes Ca 2+ from intracellular endoplasmic reticulum stores to the cytoplasm. 6 PLCβ1 expression is abundant in the cerebral cor tex, although it is widely distributed in many brain areas. 3, 7, 8 Several studies have previously reported that PLCβ1related pathways are involved in various neurophysiological func tions. 4, [9] [10] [11] [12] Moreover, decreased expression of PLCβ1 has been detected in the brains of patients with schizophrenia. [13] [14] [15] [16] [17] [18] Schizophrenia symptoms are categorized into 3 major types 19, 20 -positive, negative and cognitive -and a majority of these symptoms have been observed as endophenotypes in PLCβ1null (PLCβ1 −/− ) mice. [9] [10] [11] [12] These symptoms include increased locomotion, impaired social behaviour, impaired prepulse inhibition (PPI), and impaired working memory. [9] [10] [11] [12] Furthermore, reports of altered PLCβ1 expression in the brains of patients with schizophrenia, such as in the dorsolat eral prefrontal cortex (DLPFC), have suggested the possible pathogenic involvement of PLCβ1 in schizophrenia.
Working memory processes and provides transitory storage of information and thus plays a critical role in cognition. With out its proper operation, cognitive life would not be possible. 22 Working memory deficits have been previously reported in a number of neurologic and psychiatric disorders, including schizophrenia, Alzheimer disease, Parkinson disease and ma jor depression. [23] [24] [25] Neuroimaging studies in humans have re vealed that working memory processing is widely distributed throughout multiple brain regions, including the DLPFC. Sig nals associated with working memory are reduced in the DLPFC of patients with schizophrenia. 26, 27 In addition, DLPFC damage is associated with a deficit of working memory in hu man patients with brain damage. 28 However, molecular and cellular mechanisms responsible for working memory in the DLPFC of the human brain are poorly understood.
The human DLPFC has been shown to have anatomic as well as functional homology to the mouse mPFC, which con sists of prelimbic and infralimbic cortices. 5, [29] [30] [31] Therefore, to define a specific role for PLCβ1 in the medial prefrontal cor tex (mPFC) in the pathogenesis of schizophrenia, we pro duced mPFCselective PLCβ1knockdown mice and carried out a battery of behavioural tests designed to examine behav iours relevant to the schizophrenic endophenotypes of PLCβ1 −/− mice.
Methods

Animals
Adult male PLCβ1 −/− and wildtype littermate mice (12-16 wk of age) in a B6 × 129 F1 background were obtained by mating parental strain C57BL/6J (N26) PLCβ1 +/− and 129S4/ SvJae (N39) PLCβ1 +/− mice. 3 Mice were maintained with free access to food and water under a 12hour light/dark cycle. Animal care and experimental procedures followed the guidelines of the Institutional Animal Care and Use Commit tee of the Korea Institute of Science and Technology.
Verification of shRNA-mediated knockdown of PLC-β1
Lentiviral vectors were created as described previously. 32 Briefly, a lentiviral vector expressing a small hairpin RNA (shRNA) targeting PLCβ1 mRNA was constructed by insert ing synthetic doublestranded oligonucleotides into a shSynLenti4.4G lentiviral vector backbone containing a U6 small nuclear RNA promoter and a GFPIRESpuro r gene cassette under the control of the synapsin1 promoter. Eleven different shSynLenti4.4G lentiviral vectors encoding PLCβ1 specific shRNA (shPLCβ1) expression cassettes were tested. Validation of shRNAexpressing lentiviral vectors was per formed as described previously. 32 Of the 11 tested shRNAs, shPLCβ1-11 (target sequence, 5′CCTCCAGTGAGGAGA TAGAAA3′) effectively reduced PLCβ1 expression levels in C2C12 cells transfected with shRNAexpressing lentiviral vectors and was chosen for subsequent in vivo experiments. The scrambled shRNA (shSCR) sequence, 5′AATCG CATAGCGTATGCCGTT3′, was used to construct a nontar geting control virus.
Injection of shPLC-β1-expressing lentivirus into the mPFC
After anesthetizing wildtype mice with 2% Avertin (tribro moethyl alcohol/tertiary amyl alcohol; Aldrich), 0.3 µL of a hightiter lentiviral preparation (10 9 TU/µL) was bilaterally injected into the mPFC (+1.6 anterior-posterior, ± 0.3 medio lateral, -2.6 dorsoventral) at a rate of 0.05 µL/min using a Hamilton syringe connected to a microinjection pump (sp100i; World Precision Instruments).
Working memory
The delayed nonmatchtosample (DNMTS) Tmaze test was carried out as reported previously with minor modifica tions. 33, 34 Mice were tested using 6 trials per day, each consist ing of a forced and a choice run. In the forced run, the mouse was placed in the open arm containing a food pellet (20 mg dustless sugar pellets; Bioserv) at one end. As soon as the mouse ate the food pellet, it was placed in a dark transfer cage for a 4second delay. In the choice run, the mouse was allowed to choose between 2 open arms. A correct choice was scored when the mouse visited the alternate arm in the choice run. The criterion for successful completion of the task was 11 cor rect choices out of 12 consecutive trials (92%). Each mouse was tested for up to 15 days, during which the sequence of baiting sides (right or left) was randomized. Right/left Tmaze dis crimination was tested as described previously 34 as a positive control for any deficit in the DNMTS Tmaze task. The right/ left discrimination version of the Tmaze was carried out with the same apparatus using the same conditions as those used for the habituation procedure, but the rule for acquiring the task was different. In this case, the baiting target was fixed at one side -left or right -for all trials throughout the entire experimental period. The data were statistically analyzed using a 2tailed Student t test, a Pearson correlation test and a 2sample Kolmogorov-Smirnov test.
Locomotor activity and anxiety
Three behavioural assays for locomotor activity and anxiety were performed as described previously. 32 
Acoustic startle response and prepulse inhibition of acoustic startle
Acoustic startle response (ASR) and prepulse inhibition (PPI) tests were administered as reported previously. 35 Briefly, mice were placed into a cylinder and acclimated to the startle chamber (San Diego Instruments) for 10 minutes. The test in volved a series of 7 blocks of 8 trials (56 trials in total). The 8 trial types were a no stimulus trial; a startle stimulus alone trial in which a 40 ms, 120dB burst of white noise was pre sented; 3 different prepulse-pulse (PP) trials in which a 20 ms prepulse stimulus of different intensities (74, 82 and 90dB white noise) were presented; and 3 different trials of a PP plus a startle stimulus in which a 20 ms prepulse stimulus of different intensities (74, 82 and 90dB white noise) preceded the onset of the 120dB startle stimulus by 100 ms. We calcu lated percent PPI as described previously. 35 We assessed sta tistical significance using repeatedmeasures ANOVA and a 2tailed Student t test.
Social behaviour test
The social behaviour test was administered using previously described methods with modifications. 36, 37 The apparatus used for the social behaviour task was an openfield box (a square, white acrylic box, 40 × 40 × 40 cm) containing 2 wire cages (JEUNDO Bio & Plant) placed at opposite corners. The wire cages were 11 cm high, with a bottom diameter of 10.5 cm and bars spaced 1 cm apart. This apparatus allowed mice to make nose contact between the bars, but prevented further interaction. In the habituation period, a test mouse was placed in the social behaviour apparatus and allowed to explore for 1 hour under dim light conditions. A wildtype mouse that had no prior contact with the test mouse was en closed in 1 of the wire cages. Then, novel objects (3 Falcon tube lids) were placed in the other wire cage. The test mouse was allowed to explore the social behaviour apparatus for 10 minutes. The sniffing time for each wire cage was the dur ation of time that the nose of the test mouse was in contact with each wire cage, measured using a stopwatch. Total sniff ing time was obtained by summing the sniffing time for each wire cage. We used a 2tailed Student t test and 1way ANOVA to assess statistical significance.
Histology for PLC-β1 expression in the mPFC
To verify PLCβ1 expression in the mPFC, we performed histol ogy as described previously. 38 Every sixth section in the series throughout the entire mPFC from selected mice was used for immunohistochemistry. Sections were stained by incubation with rabbit antiPLCβ1 primary antibody (1:100; Santa Cruz Biotechnology) and then with horseradish peroxidase (HRP) conjugated secondary antibody. Immunoreactivity was visual ized with the HRP substrate 3, 3′diaminobenzidine (DAB) in 0.1 M Tris buffer. Changes in PLCβ1positive neuron morphol ogy and expression of PLCβ1 induced by shPLCβ1 in the mPFC were also evaluated by immunofluorescence staining using rabbit antiPLCβ1 primary antibody (1:100) and Cy3 conjugated secondary antisera (1:200). Sections were mounted in Vectashield mounting media with or without diamidino 2phenylindole (DAPI; Vector Laboratories). Thereafter, images were captured and analyzed using Olympus DP72 digital cam era and DP2BSW microscopic digital camera software. Figures were prepared using Adobe Photoshop 7.0. We quantified PLCβ1 immunofluorescence in RNA interferencemediated PLCβ1 knockdown mice as described previously. 32 We used 1way ANOVA to assess statistical significance.
Results
Endogenous expression of PLC-β1 in the mPFC
A previous study using in situ hybridization techniques re ported abundant expression of PLCβ1 mRNA in the mPFC of mice. 7 We performed immunohistochemical staining to de termine the level of PLCβ1 protein in the mPFC of mouse brains. PLCβ1 was highly expressed in the mPFC of wild type mice (see the Appendix, Fig. S1A , available at jpn.ca). As expected, no expression of PLCβ1 protein was detected in PLCβ1 −/− mice (Appendix, Fig. S1B and D). At higher magni fication, the morphology of PLCβ1expressing cells in the mPFC was consistent with that of neuronal cells (Appendix, Fig. S1C ). PLCβ1 expression was shown mainly in the cyto plasm within the neuronal cell body by immunofluorescence staining of PLCβ1 with DAPI (Fig. 1C) .
Silencing PLC-β1 in the mPFC
To silence PLCβ1 specifically in the mPFC, we used lentivirus mediated gene knockdown. First, we screened shPLCβ1 vec tors for shRNA sequences that effectively knocked down PLCβ1 in C2C12 cell cultures (Fig. 1A) . Eleven lentiviral vec tors encoding different shPLCβ1 expression cassettes were validated for their ability to suppress PLCβ1 expression. Of these 11 vectors, shPLCβ1-11 most effectively reduced en dogenous PLCβ1 expression in C2C12 cells (Fig. 1A , red rectangle). This vector (subsequently referred to simply as shPLCβ1) was used in all subsequent in vivo experiments. Hightitre lentiviral vectors expressing shPLCβ1 were then prepared and bilaterally injected into the mPFC of 10week old wildtype mice; mice injected with shSCR vectors (ex pressing scrambled shRNA) were used as a control group (Fig. 1B, right panel) . Because both constructs contain a green fluorescent protein reporter, we were able to determine infection efficiency and shRNA vector expression in individ ual brains in postmortem examinations conducted after be havioural studies by direct visualization with a fluorescence microscope (Fig. 1B, left panel) .
To evaluate the effects of shPLCβ1 vectors on PLCβ1 ex pression in the brain, we performed immunohistochemical analyses using a PLCβ1 antibody. Injection of shSCR had no effect on PLCβ1 immunoreactivity, which was detected at high levels in the shSCRinjected mPFC (Fig. 1C, panels 1-8) .
In contrast, endogenous PLCβ1 expression was substantially decreased in the shPLCβ1injected mPFC (Fig. 1C , panels 9-16). Infected cells labelled with DAPI showed no obvious neuronal injury, indicating that neither the lentiviral vector nor injection itself caused cytotoxicity (Fig. 1C, panels 7 and  15) . In order to quantify gene silencing in the mPFC, we com pared the percentage of PLCβ1positive neurons in the shPLCβ1injected mPFC with that in the shSCRinjected mPFC. We found that injection of the shPLCβ1 lentiviral vector induced a significant reduction (32.1% ± 2.5%) in the number of PLCβ1positive neurons (p = 0.010; Fig. 1C , panel 13, and Fig. 2D ).
Impaired working memory in mPFC-specific PLC-β1 knockdown mice
To investigate the role of mPFCspecific PLCβ1 in working memory, we administered the DNMTS Tmaze task, which requires mice to integrate information (the sample run) with the learned rule (nonmatch to sample). 33, 34 In DNMTS Tmaze tasks, shSCRinjected mice reached the criterion (correct choice on 11 of 12 consecutive trials, or 92%) within 6.18 ± 0.62 days, whereas shPLCβ1injected mice needed signifi cantly more trials to satisfy this criterion, requiring an aver age of 10.15 ± 0.95 days (p = 0.003, t test; Fig. 2A ). All shSCR injected mice reached the criterion within 10 days, but only 60% of shPLCβ1injected mice reached this criterion within this period (Fig. 2B and C) . Interestingly, a Pearson correla tion analysis showed a significant negative correlation be tween the percentages of PLCβ1positive neurons in the mPFC and the number of days required to reach the criterion of the DNMTS Tmaze task in shPLCβ1injected mice (Pearson R = -0.56, p = 0.047, ttest; Fig. 2D ). On the other hand, there was no significant difference between shPLCβ1 injected mice and shSCRinjected mice in the time to reach the criterion in the simple right/left discrimination Tmaze task (4.70 ± 0.83 d v. 5.43 ± 1.90; p = 0.30, t test; Appendix, Fig. S2A ). 34 Both shSCR and shPLCβ1injected mice reached the criterion within 10 days (Appendix, Fig. S2B ). Collec tively, these results indicate that PLCβ1 signalling in the mPFC is required for working memory. 
Normal locomotor activity and anxiety in mPFC-specific PLC-β1 knockdown mice
We next examined whether PLCβ1 deficiency in the mPFC is responsible for the hyperlocomotion and anxiolytic behav iours observed in PLCβ1 −/− mice. 10, 12 In the openfield assay, shPLCβ1injected mice showed no significant difference in the total amount of locomotor activity in the open field com pared with shSCR and vehicle (phosphatebuffered saline)-injected mice (F 2,28 = 0.317, p = 0.73; Fig. 3A and B) . Differ ences in anxiety levels could cause abnormal behaviours in cognitive tasks, including the DNMTS Tmaze task. Accord ingly, we tested shPLCβ1injected mice in 3 anxiety behav ioural assays: open field, light/dark box and elevated plus maze. The percentages of distance and time spent in the centre of an openfield arena, quantified as described in the Methods section, did not differ significantly between shPLCβ1 and shSCRinjected mice (all p > 0.05; Appendix, Figs. S3AD). In the light/dark box test, shPLCβ1injected mice exhibited no significant difference in the number of transitions from the dark to the light compartment compared with shSCRinjected mice (p = 0.84; Appendix, Fig. S3E ). Con sistent with this observation, no significant differences in the time spent in the light chamber were observed between shPLCβ1 and shSCRinjected mice (p = 0.33; Appendix, 
Normal sensorimotor gating in mPFC-specific PLC-β1 knockdown mice
To examine whether decreased mPFCspecific PLCβ1 con tributes to abnormal sensorimotor gating, we administered a PPI test, which measures the extent to which a weak prepulse stimulus attenuates the response to a subsequent startling stimulus. We measured the baseline ASR and then assessed the degree of PPI of the acoustic startle. No statistical differ ence was observed in the ASR to 120 dB between shSCR and shPLCβ1injected mice (p = 0.40, Fig. 4A ). Startle responses to 120dB pulses preceded by a prepulse of 3 different inten sities (74, 82, 90 dB; F 1,23 = 0.306, all p > 0.05; Fig. 4B ) and aver age PPI values at all 3 prepulse intensities did not differ sig nificantly between shSCR and shPLCβ1injected mice (all p > 0.05; Fig. 4C ). These results indicate that PLCβ1 signal ling in the mPFC is not related to the neural mechanism underlying PPI.
Decreased sociability of PLC-β1 −/− mice is not present in mPFC-specific PLC-β1-knockdown mice
To investigate the role of PLCβ1 in social behaviours, we first tested PLCβ1 −/− mice in a social behaviour apparatus (Fig. 5A) . 36 In this social behaviour assay, PLCβ1 −/− mice showed a decrease in total sniffing time, which is the sum of time spent sniffing an unfamiliar wildtype mouse (stranger mouse) and nonsocial novel objects, than did PLCβ1 +/+ mice (p < 0.001; Fig. 5B ). These results indicate that the PLCβ1 −/− mice exhibit decreased interest in novelty for a stranger mouse and inanimate objects compared with wildtype mice. Unlike PLCβ1 +/+ mice, which spent more time sniffing the stranger mouse than nonsocial novel objects (F 1,16 = 12.854, p = 0.002), PLCβ1
−/− mice showed no difference in sniffing time between the stranger mouse and nonsocial novel objects (F 1,20 = 3.351, p = 0.08; Fig. 5C ). These results indicate that sociability, defined as the propensity to sniff a stranger mouse more than novel inanimate objects, 36 is decreased in PLCβ1 −/− mice compared with wildtype mice. To determine whether the decreased interest in a stranger mouse or novel objects and the impaired sociability of PLCβ1 −/− mice were attributable to a PLCβ1 defect in the mPFC, we conducted a social behaviour test in mPFC specific PLCβ1 knockdown mice. The shPLCβ1injected mice showed no difference in total sniffing time compared with shSCRinjected mice (p = 0.68; Fig. 5D ). Moreover, shPLCβ1injected mice spent more time sniffing the stranger mouse than the nonsocial novel objects (F 1,24 = 48.306, p < 0.001); results were similar to those obtained with shSCR injected mice (F 1,18 = 23.050, p < 0.001; Fig. 5E ). These results indicate that PLCβ1 is required for normal social behaviours, but mPFCspecific PLCβ1 signalling is not involved in regu lating these behaviours.
Discussion
We have modelled the pathological relevance of the altered expression of PLCβ1 in the brains of patients with schizo phrenia. We demonstrated that PLCβ1 knockdown in the mPFC of the mouse causes an impairment in working mem ory, one of the key symptoms of schizophrenia. This effect was specific to working memory; there were no effects of mPFCspecific PLCβ1 knockdown on other behaviours rele vant to schizophrenic endophenotypes characteristic of PLCβ1 −/− mice (e.g., locomotion, social behaviours, senso rimotor gating).
Previous reports have shown that cytotoxic lesions or acute inactivation of the mPFC in animals induces positive, nega tive and cognitivelike schizophrenia phenotypes, including a deficit of working memory. 39, 40 These observations suggest that deficits in the mPFC represent a key component of the pathophysiology in patients with schizophrenia. 39, 40 In addi tion, decreased PLCβ1 expression in the brains of patients with schizophrenia, particularly in the DLPFC, has suggested the possible pathogenic involvement of PLCβ1 in schizo phrenia. 13, 14, 21 Here, using mPFClimited, shRNAmediated silencing of PLCβ1, we generated a mouse model that mimics the decrease of PLCβ1 in the DLPFC of patients with schizophrenia. Behavioural characterization of these model mice revealed that mPFCspecific knockdown of PLCβ1 induced only the impaired working memory phenotype without producing the altered anxiety or other schizophrenia endophenotypes previously observed in PLCβ1 −/− mice. Thus, our results suggest that the neural mechanisms under lying working memory in the mPFC may be different from those for anxiety or other schizophrenia endophenotypes of PLCβ1 −/− mice. Moreover, our results indicate that the de crease of PLCβ1 expression in the DLPFC in patients with schizophrenia is a molecular change that is relevant to the working memory deficit in those patients.
Human behavioural and functional neuroimaging studies have described decreased activation in the DLPFC in patients with schizophrenia during working memory tasks and have demonstrated that stronger prefrontalposterior parietal coup ling predicts better working memory performance in patients with schizophrenia. [41] [42] [43] In addition, abnormal brain oscillatory activity, recorded with electroencephalography (EEG) during working memory tests, has been reported in the frontal θ (4-8 Hz) and α (8-12 Hz) frequency bands of patients with schizophrenia. 44, 45 Recent human EEG studies have also de tected abnormal circuitries involving the PFC and other brain regions, such as the temporal lobe and subcortical limbic struc tures, suggesting the importance of functional connectivity be tween the PFC and these other brain regions. [46] [47] [48] Thus, altera tions in synchronized brain oscillation reflect some of the neural changes that lead to schizophrenia. 49, 50 In mice, the mPFC receives indirect projections from the dorsal hippocampus (dHPC) and direct afferent inputs from the ventral hippocampus (vHPC). 51, 52 Furthermore, the mPFC has reciprocal connections with the amygdala and other sub cortical limbic structures. 53 θFrequency synchrony between the mPFC and the dHPC and/or βfrequency (13-30 Hz) syn chrony between the mPFC and the mediodorsal thalamic nu cleus are required for working memory. 54, 55 In addition, θfrequency synchrony between the mPFC and the vHPC is important for anxiety and may suggest the involvement of the serotonergic (5HT) system. 56 Interestingly, our previous studies on PLCβ1 −/− mice have shown that generation of cholinergic θ rhythm (4-8 Hz) in the hippocampus is mainly dependent on PLCβ1 signalling. 9 The Gqcoupled muscarinic acetylcholine receptors (mAchRs), M1, M3 and M5, signal through PLCβ1. 57 The M1 mAchRs are predominant in the cerebral cortex relative to other mAchR subtypes, 58 and a decrease in M1 mAchRs in the cortex is observed in PLCβ1 −/− mice. 11 In this context, postmortem studies on the muscarinic system in schizophre nia using relatively subtypeselective radioligands have shown decreased receptor binding of the M1/M4selective antagonist [ 3 H] pirenzepine in the PFC of individuals with schizophrenia. [59] [60] [61] Furthermore, a study on mPFC mAchRs in working memory previously reported that muscarinic trans mission in the mPFC plays an important role in rodent work ing memory. 62 Sabcomeline (CDD0102A), a selective agonist of M1 mAchRs, enhances working memory in the mPFC, but not in the anterior cingulate cortex. 63, 64 Moreover, benzylqui nolone carboxylic acid, a selective positive allosteric modula tor of rat M1 mAchRs, has robust effects on M1mediated re sponses in mPFC pyramidal cells, increases the firing of mPFC neurons in vivo, and improves mPFCdependent forms of cognitive function. 65 Thus, it is expected that modu lation of cholinergic θ rhythms by the M1PLCβ1 pathway in the mPFC may be involved in the functional connections among brain regions related to working memory. Although our current findings demonstrate the effect of mPFC PLCβ1 silencing in mice, additional studies designed to investigate G proteincoupled receptors linked to PLCβ1 in the mPFC will be necessary to fully elucidate the role of PLCβ1 signal ling in the pathogenesis of schizophrenia.
Limitations
Other behavioural phenotypes of PLCβ1 -/-mice, such as openfield, DNMTS Tmaze, PPI, elevated plusmaze, and a light/dark transition task, have already been published in our previous studies, 10, 12 and these behavioural tests of mPFCspecific PLCβ1 knockdown mice were performed under the same experimental conditions as performed previ ously with PLCβ1 -/-mice. On the other hand, the sociability test was not done for the PLCβ1 -/-mice previously. There fore, only social behavioural results of PLCβ1 -/-mice and mPFCspecific PLCβ1 knockdown mice were included in the present study. Furthermore, from our present results, we in fer that a similar process is happening in human schizophre nia. Nevertheless, we are aware of the possibility that the neural mechanisms underlying the working memory deficit in mice may be different from those in human schizophrenia. Understanding the pathophysiology for schizophrenia with our present study remains limited and raises more questions in this regard. We hope that these questions will be impor tant for future indepth studies, preferably in humans.
Conclusion
Our behavioural analysis of mPFCspecific PLCβ1 knock down mice offers new insight into PLCβ1 hypofunction in the pathogenesis of schizophrenia and may further the under standing of neural mechanisms underlying working memory deficits in human schizophrenia.
